Authors: Mochida-Nishimura, K Surewicz, K Cross, JV Hejal, R Templeton, D Rich, EA Toossi, Z

Citation: K. Mochida-nishimura et al., Differential activation of MAP kinase signaling pathways and nuclear factor-kappa B in bronchoalveolar cells of smelters and nonsmokers, MOL MED, 7(3), 2001, pp. 177-185

Authors: Tang, H Hornstein, E Stolovich, M Levy, G Livingstone, M Templeton, D Avruch, J Meyuhas, O

Citation: H. Tang et al., Amino acid-induced translation of TOP mRNAs is fully dependent on phosphatidylinositol 3-kinase-mediated signaling, is partially inhibited by rapamycin and is independent of S6K1 and rpS6 phosphorylation, MOL CELL B, 21(24), 2001, pp. 8671-8683

Authors: Mistry, P Stewart, AJ Dangerfield, W Okiji, S Liddle, C Bootle, D Plumb, JA Templeton, D Charlton, P

Citation: P. Mistry et al., In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576, CANCER RES, 61(2), 2001, pp. 749-758

Authors: Chen, G Templeton, D Suttle, DP Stacey, DW

Citation: G. Chen et al., Ras stimulates DNA topoisomerase II alpha through MEK: A link between oncogenic signaling and a therapeutic target, ONCOGENE, 18(50), 1999, pp. 7149-7160

Authors: Hayward, TK Hamilton, J Templeton, D Jennings, E Ruth, M Tholudur, A McMillan, JD Tucker, M Mohagheghi, A

Citation: Tk. Hayward et al., Enzyme production, growth, and adaptation of T-reesei strains QM9414, L-27, RL-P37, and Rut C-30 to conditioned yellow poplar sawdust hydrolysate - Scientific note, APPL BIOC B, 77-9, 1999, pp. 293-309

Authors: Mistry, P Plumb, J Eccles, S Watson, S Dale, I Ryder, H Box, G Charlton, P Templeton, D Bevan, PB

Citation: P. Mistry et al., In vivo efficacy of XR9051, a potent modulator of P-glycoprotein mediated multidrug resistance, BR J CANC, 79(11-12), 1999, pp. 1672-1678